Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients.
Saved in:
| Title: | Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients. |
|---|---|
| Authors: | Almeida, Pedro R. J.1 (AUTHOR), Periard, Alexandre M.1 (AUTHOR), Tana, Fernanda L.1 (AUTHOR), Avila, Renata E.2 (AUTHOR), Milhorato, Larissa B.1 (AUTHOR), Alcantara, Katlen M. M.1 (AUTHOR), Resende, Carolina B.1 (AUTHOR), Serufo, Angela V.1 (AUTHOR), Santos, Felipe R.1 (AUTHOR), Teixeira, Danielle C.1 (AUTHOR), Queiroz‐Junior, Celso M.1 (AUTHOR), Fonseca, Talita C. M.1 (AUTHOR), Silva, Barbara L. V.1 (AUTHOR), Costa, Vivian V.1 (AUTHOR), Souza, Renan P.3 (AUTHOR), Perretti, Mauro4 (AUTHOR), Jonassen, Thomas E. N.5 (AUTHOR), Teixeira, Mauro M.1,6 (AUTHOR) mmtex.ufmg@gmail.com |
| Source: | British Journal of Pharmacology. Dec2024, Vol. 181 Issue 23, p4750-4765. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
